LACTOSE (INDIA)
|
LACTOSE (INDIA) Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 4.10 | 5.39 | 0.96 | 1.95 | -2.17 |
| CEPS(Rs) | 8.38 | 9.54 | 4.68 | 5.57 | 1.64 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 41.48 | 37.41 | 32.22 | 31.21 | 30.15 |
| Tax Rate(%) | 25.37 | 29.75 | 17.47 | 22.58 | 24.24 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 14.49 | 16.67 | 17.29 | 26.69 | 17.80 |
| EBIT Margin(%) | 11.19 | 13.10 | 11.27 | 18.03 | 6.23 |
| Pre Tax Margin(%) | 5.94 | 8.49 | 2.23 | 6.89 | -9.35 |
| PAT Margin (%) | 4.44 | 5.96 | 1.84 | 5.34 | -7.09 |
| Cash Profit Margin (%) | 9.07 | 10.54 | 8.96 | 15.26 | 5.38 |
| Performance Ratios | |||||
| ROA(%) | 4.41 | 6.72 | 1.26 | 2.75 | -2.88 |
| ROE(%) | 10.40 | 15.49 | 3.03 | 6.65 | -7.21 |
| ROCE(%) | 13.01 | 18.18 | 9.27 | 10.21 | 2.81 |
| Asset Turnover(x) | 0.99 | 1.13 | 0.69 | 0.51 | 0.41 |
| Sales/Fixed Asset(x) | 1.34 | 1.36 | 0.81 | 0.58 | 0.46 |
| Working Capital/Sales(x) | 9.36 | 11.34 | 6.02 | 5.86 | 4.33 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.74 | 0.74 | 1.24 | 1.73 | 2.20 |
| Receivable days | 58.07 | 44.69 | 66.13 | 70.62 | 70.00 |
| Inventory Days | 64.83 | 63.41 | 82.93 | 61.34 | 89.94 |
| Payable days | 67.48 | 95.77 | 172.65 | 165.11 | 253.97 |
| Valuation Parameters | |||||
| PER(x) | 21.63 | 25.87 | 45.81 | 30.79 | - |
| PCE(x) | 10.58 | 14.63 | 9.39 | 10.77 | 16.24 |
| Price/Book(x) | 2.14 | 3.73 | 1.37 | 1.92 | 0.89 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.40 | 1.86 | 1.41 | 2.51 | 2.12 |
| EV/Core EBITDA(x) | 8.85 | 10.52 | 7.67 | 8.97 | 11.33 |
| EV/EBIT(x) | 12.51 | 14.20 | 12.52 | 13.91 | 33.99 |
| EV/CE(x) | 1.42 | 2.49 | 1.18 | 1.28 | 0.84 |
| M Cap / Sales | 0.96 | 1.54 | 0.84 | 1.64 | 0.87 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 2.20 | 73.09 | 43.23 | 31.39 | -12.70 |
| Core EBITDA Growth(%) | -8.56 | 66.44 | -5.79 | 96.48 | -31.65 |
| EBIT Growth(%) | -12.71 | 101.24 | -10.50 | 280.34 | -61.50 |
| PAT Growth(%) | -23.95 | 461.77 | -50.70 | 198.94 | -3,540.97 |
| EPS Growth(%) | -23.95 | 461.77 | -50.70 | 189.89 | -3,163.95 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 1.08 | 0.81 | 0.95 | 1.06 | 1.34 |
| Current Ratio(x) | 1.28 | 1.40 | 1.41 | 1.53 | 1.69 |
| Quick Ratio(x) | 0.73 | 0.73 | 0.55 | 1.05 | 0.98 |
| Interest Cover(x) | 2.13 | 2.84 | 1.25 | 1.62 | 0.40 |
| Total Debt/Mcap(x) | 0.50 | 0.22 | 0.69 | 0.55 | 1.51 |
Compare Financial Ratios of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹134.9 Cr | -5.4% | -13.1% | -38% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,529.0 Cr | 2.7% | 3.7% | -6.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,067.0 Cr | -5.3% | 0.6% | 10% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,376.0 Cr | 7.5% | 8.1% | 19.2% | Stock Analytics | |
| CIPLA | ₹122,773.0 Cr | 1.3% | -2.7% | -5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,595.0 Cr | 2% | -2.8% | -7% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -5.4% |
-13.1% |
-38% |
| SENSEX | 1.2% |
2.8% |
6.3% |
You may also like the below Video Courses
